Daily FNArena News

With biotechnology in focus in 2020, Race Oncology is attracting investor interest

Fineos Corp, the global insurance industry software provider, has hit the ground running on the ASX with a stellar growth outlook

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

SPONSORED: Having raised $650,000 to be used for the technical development of its Motif Micro and Connect Platform technologies, business development and marketing costs, product authentication and consumer engagement solutions provider YPB Group is in a strong position to continue its momentum

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Nanosonics remains a quality, structural growth story but the extensive delay in launching a second Trophon product has frustrated investors.

SPONSORED: The release of Minbos Resources’ Scoping Study demonstrates this company could achieve robust returns in the near future, as it looks to its goal of building a nutrient supply and distribution business that stimulates agricultural production and promotes food security in sub-Saharan Angola and the broader Congo Basin.

Peter Switzer of the Switzer Report singles out two stalwarts and two newer companies for consideration.

A glance through the latest expert views and predictions about commodities. Iron ore; gold; alumina; metallurgical coal; and chrome.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments